Enhancer ID: | E_01_0873 |
Species: | human |
Position : | chr10:103084318-103086318 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Acute lymphoblastic leukemia |
Pubmed ID: | 33124053 |
Enhancer experiment: | NT5C2 recombinant protein production and 5-nucleotidase activity assay |
Enhancer experiment description: | A recent genomewide association study has identified germline polymorphisms (e.g., rs72846714) in the NT5C2 gene associated with 6-MP metabolism in patients with ALL. However, the full spectrum of genetic variation in NT5C2 is unclear and its impact on 6-MP drug activation has not been comprehensively examined. |
Target gene : | NT5C2 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | A recent genomewide association study has identified germline polymorphisms (e.g., rs72846714) in the NT5C2 gene associated with 6-MP metabolism in patients with ALL. However, the full spectrum of genetic variation in NT5C2 is unclear and its impact on 6-MP drug activation has not been comprehensively examined. |
TF name : | -- |
TF experiment: | NT5C2 recombinant protein production and 5-nucleotidase activity assay |
TF experiment description: | A recent genomewide association study has identified germline polymorphisms (e.g., rs72846714) in the NT5C2 gene associated with 6-MP metabolism in patients with ALL. However, the full spectrum of genetic variation in NT5C2 is unclear and its impact on 6-MP drug activation has not been comprehensively examined. |
Enhancer function : | A recent genomewide association study has identified germline polymorphisms (e.g., rs72846714) in the NT5C2 gene associated with 6-MP metabolism in patients with ALL. However, the full spectrum of genetic variation in NT5C2 is unclear and its impact on 6-MP drug activation has not been comprehensively examined. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
A recent genomewide association study has identified germline polymorphisms (e.g., rs72846714) in the NT5C2 gene associated with 6-MP metabolism in patients with ALL. However, the full spectrum of genetic variation in NT5C2 is unclear and its impact on 6-MP drug activation has not been comprehensively examined. |
SNP ID: | rs10883841,rs12256506,rs7091462,rs12240508 |
GeneName | Pathway Name | Source | Gene Number |
---|